Background {#Sec1}
==========

Hepatocellular carcinoma (HCC) ranks fifth in the global incidence of malignant tumors, and HCC-related mortality ranks third \[[@CR1]\]. The burden imposed by the diagnosis of liver cancer is particularly prominent in China \[[@CR2]\]. For the treatment of early-stage liver cancer, commonly accepted radical treatments include liver transplant (LT), liver resection, and radiofrequency ablation (RFA). LT not only removes the lesion but also removes the substrate for growth of the tumor, and it is generally considered the most effective method \[[@CR3]\]. However, liver resection and RFA are the main treatments for early HCC. Comparison of safety and effectiveness between liver resection and RFA has been the subject of much research interest for the past several years \[[@CR4]\].

Although a unified understanding has not been reached, analysis of effectiveness has generally indicated that long-term survival and tumor recurrence are similar between these methods for small liver tumors with a diameter ≤ 3 cm \[[@CR5]\]; for liver tumors with a diameter \> 5 cm, it is currently believed that RFA cannot achieve the effect of radical treatment \[[@CR6]\]. However, for liver tumors with diameters of 3--5 cm, there is still considerable controversy regarding the effect of RFA \[[@CR7]--[@CR9]\]. Additionally, most studies comparing these two methods have focused on the treatment or control of the tumor, whereas the safety of the two treatment methods has been ignored. Nonetheless, safety remains an issue that must be considered when selecting treatment. Therefore, this study was performed to comprehensively examine the efficacy and safety of liver cancer (diameter 3--5 cm) treatment with resection and RFA using data collected at our center.

Methods {#Sec2}
=======

Patients {#Sec3}
--------

This retrospective study was performed after approval from the Ethics Committee of our hospital. Written informed consent was obtained from all patients for publication of data as well as any accompanying images and videos. We retrospectively collected all liver cancer patients admitted to our hospital from Jan 2011 to Dec 2015; the cases were screened according to inclusion and exclusion criteria (shown in Table [1](#Tab1){ref-type="table"}). Ultimately, we collected 122 patients for group analysis. Table 1Main inclusion/exclusion criteria of the studyInclusion criteria Single tumor 3 cm ≤ diameter of tumor\< 5 cm ECOG score 0--1 Liver function of grade Child A or B Receiving the first treatment in our center: liver resection or RFA All cases were accomplished with laparotomy Able to receive the complete postoperative regular follow-up visit or inspectionExclusion criteria Tumor thrombus in major vessels Multiple tumors, or distant metastasis The heart and lung function of the patients cannot tolerate surgical treatment Cannot take the surgery due to other diseases Cases with preoperative intervention of HIFU knife on the lesion or other preoperative relevant downgrade treatment Liver function at level C (patients achieving levels A or B after liver-protection treatment can be incorporated) Cases with postoperative diagnosis of biliary carcinoma or other non-liver-cell liver cancer Cases that received other treatment means Cases without follow-up after the surgery Other treatment cases that adopted intravenous chemotherapy or took sorafenib after the surgery Other surgical contraindications, such as coagulation disorders

We divided the 122 patients into a liver resection group and an RFA group according to the treatment strategy applied, with the liver resection group including 72 patients and the RFA group 50 patients. We compared the following intraoperative data for the two groups: surgical time, blood loss due to hepatic portal occlusion, and transfusion rate. We also compared relevant postoperative data, and the Clavien evaluation system was employed to assess the occurrence of postoperative complications. We then compared 1-, 3-, and 5-year overall survival rates and tumor-free survival rates. The surgical procedures and follow-up protocol have been introduced in our previous publications \[[@CR10]--[@CR12]\].

Statistical analysis {#Sec4}
--------------------

We used SPSS 17.0 (SPSS Inc. Chicago, IL, USA) for statistical analysis of the data. Patient baseline characteristics and other continuous variables were compared and calculated using the non-parametric Wilcoxon test because some of the measurements did not have normal distributions; the results are expressed as the mean ± SD. Categorical data, which are expressed as frequencies, were compared using the Chi-squared test or Fisher's exact test, as appropriate. Ranked data were compared using the Mann-Whitney U test. Overall survival and tumor-free survival rates were obtained by Kaplan-Meier survival analysis, and differences in survival curves between the two groups were statistically compared by the log-rank test. Univariate analysis was performed to identify factors predicting overall and tumor-free survival. All variables with *P* \< 0.05 were included in multivariate analysis using Cox regression to assess independent predictive factors. Two-sided *P* values \< 0.05 were considered statistically significant. Ultimately, biological characteristics and common sense must be combined to determine clinical significance.

Results {#Sec5}
=======

Clinical and pathological characteristics {#Sec6}
-----------------------------------------

As shown in Table [2](#Tab2){ref-type="table"}, we found no significant difference in demographic baseline characteristics among the patients in the two groups (*P* \> 0.05). Furthermore, differences in preoperative liver function between the two groups was not statistically significant according to either the Child scoring system or the MELD scoring system. Table 2Comparison between baseline data and oncological features of patients in resection group and RFA groupLiver resection groupRFA group*P* value7250Age46.7 ± 10.345.8 ± 12.00.664Gender (male/female)61/1142/80.914Weight (Kg)68.1 ± 9.566.8 ± 10.00.474Height (cm)166.9 ± 8.4163.5 ± 8.40.057BMI (kg/m^2^)23.3 ± 2.423.8 ± 1.80.252Ethnicity(Han//Tibet/Yi/Others)63/4/2/345/2/2/10.665Virological examination(B/C/negative)67/1/446/4/00.899HBV-DNA (negative/positive)28/3925/210.191Child score (A/B/C)47/25/037/13/00.308MELD score5.5 ± 2.25.4 ± 1.50.688Ishak score3.9 ± 1.54.1 ± 1.20.411Tumor diameter (cm)3.7 ± 0.53.8 ± 0.50.528Preoperative AFP level (ng/ml)3781.9 ± 14,105.94716.6 ± 14,813.60.725Preoperative AFP (−/+/++/+++)33/10/10/1919/8/8/150.444Degree of tumor differentiation(low/moderate/high)15/27/3016/19/150.116Tumor location (edge/center)53/1912/380.000Microvascular invasion (yes/no)23/4917/330.813HBV DNA negative: \< 1.0E+ 03 copies/ml, positive: ≥1.0E+ 03 copies/mlOther ethnicities: Qiang and MongolianPreoperative AFP level: -: \< 12 ng/ml; +: 12 ng/ml ≤ \< 400 ng/mL; ++: 400 ng/ml \< ≤1200 ng/mL; +++: ≥1200 ng/mlContinuous variables compared and calculated by using non-parametric Wilcoxon tests, frequencies for categorical data, and compared by using the Chi-squared test or Fisher's exact test if necessary, ranked data were compared by using Mann-Whitney U test

Regarding the comparison of cancer characteristics, the cases analyzed all involved single lesions. Although our results indicated that the tumor diameter for the RFA group was slightly larger than that for the resection group (3.8 vs. 3.7 cm), this difference was not statistically significant (*P* = 0.528). Regarding the position of the tumor in the liver, the tumor was located on the edge in 53 cases of the resection group (73.6%) but in only 12 cases (24.0%) for the RFA group (*P* \< 0.01). This difference is mainly because the advantages and disadvantages of RFA and resection cause the surgeon to adopt the optimal treatment plan before or during surgery.

Intraoperative and short-term outcomes {#Sec7}
--------------------------------------

Table [3](#Tab3){ref-type="table"} presents the comparison of relevant intra- and postoperative data for the resection and RFA groups. The operative time of the resection group was significantly longer than that of the RFA group (4.0 vs. 2.7 h, *P* \< 0.001). In addition, intraoperative blood loss was significantly greater in the resection group than in the RFA group (364.6 vs. 102.0 ml, *P* \< 0.001), and hepatic portal occlusion occurred significantly more often in the resection group than in the RFA group (*P* \< 0.001). We also found that the average hospital stay of the resection group was 6.3 days, which was significantly longer than the 4.7 days for the RFA group (*P* = 0.001). Table 3Comparison of relevant intra-operative data and post-operative short-term recovery situation between the two groupsResection groupRFA group*P* value7250Operation time (hours)4.0 ± 1.22.7 ± 0.8\< 0.001Intra-operative blood loss (ml)364.6 ± 180.1102.0 ± 105.9\< 0.001Intra-operative transfusion (Yes/No)9/633/470.238Hepatic inflow occlusion (whole liver/half9/36/272/4/44\< 0.001liver/non-blocking)ICU care (Yes/No)5/673/470.836Total number of days in hospital6.3 ± 2.24.7 ± 1.80.001Total cost of hospitalization (RMB Yuan)35,542 ± 2456.933,453.2 ± 1986.60.939*ICU* Intensive care unitContinuous variables compared and calculated by using non-parametric Wilcoxon tests, frequencies for categorical data, and compared by using the Chi-squared test or Fisher's exact test if necessary,

We adopted the Clavien system to summarize and compare the occurrence of postoperative complications between the two groups (Table [4](#Tab4){ref-type="table"}). In the resection group, 18 patients experienced complications, for a total occurrence rate of 25%; in the RFA group, there were 8 patients with complications, for a total occurrence rate of 16%. Although the occurrence rate of complications was higher in the resection group than in the RFA group, the difference was not statistically significant (*P* = 0.284). The occurrence rate of serious complications (≥level III) was 8.3% for the resection group and 4% for the RFA group, with no significant difference (*P* = 0.344). In the RFA group, there was one case of postoperative fever. Color ultrasonography and computed tomography (CT) revealed the formation of biloma with abscess, and we performed laparotomy abdominal inspection to conduct a partial liver resection. Table 4Comparison of post-operative complication occurrence for resection group and radiofrequency group (Clavien scoring system)Resection groupRFA group7250Clavien level I (without drugs, conservative treatment)7 (9.7%)4 (8%)Incision fat liquefaction21Wound infection12Pleural effusion21Biliary fistula20Clavien level II (simple medicine treatment)5 (6.9%)2 (4%)Wound infection21Postoperative pulmonary infection11Postoperative abdominal hemorrhage20Clavien level IIIa (therapeutic operation1 (1.4%)0 (0%)under local anesthesia)Pleural effusion10Clavien level IIIb (operational treatment1 (1.4%)1 (2%)under general anesthesia)Abdominal hemorrhage10Biloma01Clavien level IVa (single organ function failure)2 (2.8%)1 (2%)Respiratory failure10Liver failure11Clavien level IVb (multiple organ failure)1 (1.4%)0 (0%)Hepatorenal syndrome10Clavien level V (death)1 (1.4%)0 (0%)Septic shock10

Long-term outcome {#Sec8}
-----------------

During the follow-up period, the 1-, 3-, and 5-year expected overall survival rates for the resection group were 94.4, 77.8, and 70.8% vs 90, 76, and 68% for the RFA group, as illustrated in Fig. [1](#Fig1){ref-type="fig"}. However, these differences were not statistically significant (*P* = 0.968). The 1-, 3-, and 5-year expected tumor-free survival rates were 87.5, 62.5, and 55.6% and 88, 68, and 60% in the resection and RFA groups, respectively. As shown in Fig. [2](#Fig2){ref-type="fig"}, the difference between the two groups was not statistically significant (*P* = 0.620). During the follow-up period, 41 patients died, and 52 experienced HCC recurrence. The most common recurrence or metastasis location of postoperative tumors was the liver (55%). Extrahepatic recurrence and metastasis occurred mostly in the lung (30%), followed by intra-abdominal metastasis (7.5%); bone metastasis was rare (5%), as was metastasis to other parts of the body (2.5%). The most common treatment for tumor recurrence was transcatheter arterial chemoembolization (TACE) (28 cases), followed by re-resection (11 cases) or RFA (21 cases); in contrast, LT (2 cases), high-intensity focused ultrasound (HIFU) knife (3 cases), and other treatment programs \[including sorafenib (2 cases), chemotherapy (1 case), and radiotherapy (1 case)\] were rare. The most common factor causing death during the postoperative follow-up period was tumor recurrence and metastasis (78%), followed by liver function failure (19.5%); other causes were rare (2.4%). Fig. 1Comparison of 1-, 3-, and 5-year expected overall survival rates for the treatment of small liver cancer with diameters of 3--5 cm between abdominal RFA and resection groups; no significant differences were found. For the resection group, the values were 94.4, 77.8, and 70.8%, respectively, and for the radiofrequency group, the values were 90, 76, and 68%, respectively (*P* = 0.968) Fig. 2Comparison of 1-, 3-, and 5-year expected tumor-free survival rates for patients in resection and RFA groups with respect to small liver tumors with diameters of 3--5 cm. For the resection group, these values are 87.5, 62.5, and 55.6%, respectively, and for the RFA group, these values are 88, 68, and 60%, respectively (*P* = 0.620)

Univariate and multivariate analyses {#Sec9}
------------------------------------

As shown in Table [5](#Tab5){ref-type="table"}, univariate analysis identified the preoperative neutrophil-lymphocyte ratio (NLR) ≥ 4 (*P* \< 0.001), AFP ≥400 ng/ml (*P* = 0.014), intra-operative blood loss≥400 ml (*P* = 0.029), poor histological grade (*P* \< 0.029), central tumor location (*P* = 0.044), and microvascular invasion (*P* \< 0.001) as being significant factors contributing to overall survival after surgery. Multivariate analysis of the five factors found to be significant in univariate analysis further identified NLR ≥ 4 (*P* = 0.020) and poor histological grade (P \< 0.001) as significant contributors to overall survival. The hazard ratios (HRs) and 95% confidence intervals (CIs) for these factors are provided in Table [6](#Tab6){ref-type="table"}. Table 5Univariate analyses contributing to overall survival and tumor-free survival rate after RFA or ResectionVariablesN (122)Overall survival rateTumor-free survival rate*P* Value*P* ValueAge ≥ 60 (yes/no)19/1030.3980.961Gender (M/F)103/190.3980.652Race (Han/other)108/140.1700.083BMI ≥ 26 (yes/no)13/1090.8210.751Causes of liver diseases (HBV/other)113/90.1500.419Child Score (A/B)84/380.2550.389Hemoglobin \<120 g/L(yes/no)44/780.4800.766Platelet \<100\*10\^9/L(yes/no)40/740.1940.029NLR ≥ 4 (yes/no)62/60\<0.001\<0.001AFP ≥400 ng/ml (yes/no)52/700.0140.059Tumor diameter (3--4/4--5)56/660.4880.296Radical therapy (RFA/ Resection)50/720.9400.629Tumor location (center/edge)57/650.0440.358Intra-operative blood loss≥400 ml38/840.0290.161(yes/no)44/45/33\<0.0010.212Histological grading (well/moderate/poor)Microvascular invasion (yes/no)40/82\<0.001\<0.001*NLR* Neutrophil-lymphocyte ratio, *AFP* Alpha-fetoprotein *BMI* Body mass index, *HBV* Hepatitis B virus, *M* Male; *F* Female Table 6Multivariate analyses contributing to overall survival and tumor-free survival rateVariablesHazard ratio95% CI*P*-valuePrognostic factors for overall survivalNLR ≥ 41.4531.072--2.2870.020AFP ≥400 ng/mlIntra-operative blood loss ≥ 400 ml1.8641.2191.021--3.2100.829--2.0830.1020.398Histological grading Well Moderate2.2111.806--3.1270.046 Poor2.6801.346--4.632\<0.001Tumor located central1.4581.091--1.7620.469Microvascular invasion2.2091.210--3.2900.016Treatment modality (Resection/RFA)1.5421.105--3.0260.895Prognostic factors for tumor-free survivalPlatelet \<100\*10\^9/L1.7821.142--2.8910.142NLR ≥ 41.3741.201--2.347\<0.001Microvascular invasion1.6181.082--2.2890.015Treatment modality (Resection/RFA)1.7621.052--2.2170.651*NLR* Neutrophil-lymphocyte ratio, *AFP* Alpha-fetoproteinCox regression was used in multivariate analysis

Table [5](#Tab5){ref-type="table"} shows that preoperative platelet count \< 100\*10^9^/L (*P* = 0.029), NLR ≥ 4, and microvascular invasion (P \< 0.001) were significant factors contributing to lower long-term tumor-free survival. Multivariate analysis indicated NLR ≥ 4 and microvascular invasion as risk factors for tumor recurrence (Table [6](#Tab6){ref-type="table"}).

Discussion {#Sec10}
==========

In general, surgical resection is a more radical treatment approach than is RFA. However, due to the limitations of liver condition and function, postoperative complications also need to be taken into account. RFA surgery is a relatively safe treatment approach, but the stability and thoroughness of RFA for treating liver cancer are difficult to determine \[[@CR13], [@CR14]\]. Although evaluation of effectiveness between the two approaches is still being performed, in Western countries, especially in the United States, treatment guidelines for liver cancer consistently recommend surgical resection for early liver cancer in cases of adequate liver function and the absence of high venous pressure \[[@CR15]\]. However, the guidelines also mention that due to the nearly 3% mortality rate after liver resection surgery, the use of other therapies to treat small liver tumors may be appropriate, with ablation treatment being preferred. At present, RFA is the relevant mature ablation treatment method, and there have been many studies on the effectiveness and reliability of RFA and surgical resection for the treatment of liver cancer. Despite the lack of a unified opinion, we believe that the effect of RFA depends on the maximum diameter of the tumor. Current studies mostly define RFA as the gold standard for tumors smaller than 2.3--3 cm. For a single tumor with a diameter smaller than 3 cm, RFA can achieve results similar to those of resection, and the safety of the patient is ensured \[[@CR16]--[@CR18]\]. Nonetheless, although some reports claim that three-dimensional RFA can achieve similar results to resection for a tumor with a diameter in excess of 5 cm, most reports to date indicate the use of resection instead of RFA \[[@CR4]\]. Regardless, the focus of the current debate is for a single liver tumor that is 3--5 cm in diameter, and for these tumors, the treatment effectiveness of RFA and resection remain to be further investigated. Thus, our study was conducted to promote an in-depth discussion on this subject.

Regarding tumor characteristics, there were more cases of the tumor located in the center of liver in the RFA group than in the resection group, mainly due jointly to preoperative CT evaluation and intraoperative examination of tumor features and liver cirrhosis. That is, when the tumor is located in the periphery of the liver, surgical resection is relatively easy, especially for a tumor in the left lateral lobe; in contrast, RFA ablation is prone to injuring surrounding tissues, such as the stomach or colon \[[@CR6]\]. In addition, the implementation of RFA for peripheral small liver tumors may cause tumor rupture and result in metastasis \[[@CR4], [@CR19]\]. When the tumor is located in the center of the liver, however, especially at the junction of the donor in segments V, VI, VII, and VIII of the right side of the liver, resection will result in the loss of a large amount of normal liver tissue, leaving too small a volume in the residual liver \[[@CR19]\]. Because much of the liver is cirrhotic in these patients, postoperative liver function cannot satisfy organ metabolism, leading to liver failure or even death. Moreover, when the tumor is close to large blood vessels, the result of RFA is poor, and part of the tumor tissue often remains. Therefore, in the clinical application of RFA, we need to consider not only the diameter of the tumor but also its location, the surrounding tissue and the underlying liver condition to achieve the best results.

The small incision with RFA surgery tends to result in significantly less blood loss; cases requiring blood transfusion were rare in this study because the blood loss during resection surgery was also small in our hospital. Therefore, although blood loss differed between the two groups, there was no significant difference in the rate of blood transfusion. Because the trauma of resection is relatively great, the surgery requires partial occlusion. The most commonly used method is semi-liver occlusion, which can prevent injury to the remaining liver due to continuous occlusion by ischemia-reperfusion. In our analysis, the intraoperative time was short, the blood loss during surgery was small, and the postoperative hospital stay was short; however, there was still a significant difference between the total treatment expense for the RFA and resection groups, mainly because domestic hospitals generally use imported RFA needles. The RFA needle costs nearly 10,000 RMB Yuan, which accounts for most of the treatment cost of RFA, whereas the overall expense of surgical resection is low. Hence, there was no difference in total treatment expense between the groups. Through the observation of postoperative complications, we found that although the occurrence rates of postoperative complications and serious complications were higher among the patients in the resection group than in the RFA group, this difference was not statistically significant. One possible reason may be that our sample size was not large enough and that abdominal surgery was performed for all our cases of RFA. Therefore, in comparison with other statistical analyses, our data are more objective and accurate. Regardless, a multi-center randomized comparison and a large sample are needed to further explore the occurrence of postoperative complications for the two methods.

Our analysis indicated similar postoperative 1-, 3-, and 5-year survival rates for the RFA and resection groups, which is similar to the results of the 18th national statistical analysis of Japan in which a statistical analysis of over 10,000 cases of liver cancer with level A liver function was conducted. In that analysis, RFA not only achieved a similar result to resection for liver tumors smaller than 2 cm but also for liver tumors 2--5 cm in diameter, with the observations extending up to 10 years \[[@CR20]\]. Our univariate and multivariate analyses of factors contributing to overall survival and tumor-free survival rates indicated that neither resection nor RFA influenced overall survival or tumor-free survival. Our study again corroborates this point.

There are some limitations of this study. Although the sample size was relatively large, all patients were from a single center, and the study of patients from multiple centers is more persuasive. In addition, this was a retrospective analysis: we retrospectively collected and compared the characteristics of two groups of patients. Because our selection of resection or RFA before and during surgery is mainly determined according to the position of the tumor on preoperative CT and during the surgery, the method was not assigned randomly. Hence, a multi-center randomized comparative study with a large sample will be more persuasive, and this is the direction of our future work.

Conclusion {#Sec11}
==========

Because there are fewer complications after RFA surgery, which has better intraoperative and postoperative performance and a postoperative survival rate comparable to that of resection surgery, abdominal RFA can be considered for wide application to single tumors with diameters of 3--5 cm, especially for cases in which the tumor is in a central location.
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